Specialty Retail
Compare Stocks
5 / 10Stock Comparison
RERE vs BACK vs EBAY vs ATXI vs XTLB
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Specialty Retail
Biotechnology
Biotechnology
RERE vs BACK vs EBAY vs ATXI vs XTLB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Retail | Medical - Care Facilities | Specialty Retail | Biotechnology | Biotechnology |
| Market Cap | $1.10B | $78K | $48.63B | $2M | $294K |
| Revenue (TTM) | $18.54B | $23K | $11.60B | $1M | $451K |
| Net Income (TTM) | $210M | $-10M | $2.04B | $-4M | $-1M |
| Gross Margin | 20.5% | -18.4% | 72.0% | 100.0% | 26.4% |
| Operating Margin | 1.3% | -398.1% | 19.6% | -279.8% | -481.6% |
| Forward P/E | 1.5x | — | 17.4x | — | — |
| Total Debt | $355M | $0.00 | $7.38B | $0.00 | $138K |
| Cash & Equiv. | $1.97B | $504K | $1.87B | $3M | $371K |
RERE vs BACK vs EBAY vs ATXI vs XTLB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| ATRenew Inc. (RERE) | 100 | 30.2 | -69.8% |
| IMAC Holdings, Inc. (BACK) | 100 | 0.1 | -99.9% |
| eBay Inc. (EBAY) | 100 | 151.6 | +51.6% |
| Avenue Therapeutics… (ATXI) | 100 | 0.0 | -100.0% |
| XTL Biopharmaceutic… (XTLB) | 100 | 16.7 | -83.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RERE vs BACK vs EBAY vs ATXI vs XTLB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RERE has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 25.9%, EPS growth 94.7%, 3Y rev CAGR 28.0%
- Lower volatility, beta 1.36, Low D/E 9.6%, current ratio 3.19x
- 25.9% revenue growth vs XTLB's -173.2%
- Better valuation composite
BACK is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.05, yield 100.0%
- Beta 0.05, yield 100.0%, current ratio 0.09x
- Beta 0.05 vs XTLB's 1.71
- 100.0% yield, 1-year raise streak, vs EBAY's 1.1%, (3 stocks pay no dividend)
EBAY ranks third and is worth considering specifically for long-term compounding.
- 369.5% 10Y total return vs RERE's -73.2%
- 17.6% margin vs BACK's -426.9%
- 11.5% ROA vs BACK's -31.3%
ATXI is the clearest fit if your priority is momentum.
- +150.1% vs XTLB's -50.9%
Among these 5 stocks, XTLB doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.9% revenue growth vs XTLB's -173.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 17.6% margin vs BACK's -426.9% | |
| Stability / Safety | Beta 0.05 vs XTLB's 1.71 | |
| Dividends | 100.0% yield, 1-year raise streak, vs EBAY's 1.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +150.1% vs XTLB's -50.9% | |
| Efficiency (ROA) | 11.5% ROA vs BACK's -31.3% |
RERE vs BACK vs EBAY vs ATXI vs XTLB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
RERE vs BACK vs EBAY vs ATXI vs XTLB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EBAY leads in 3 of 6 categories
RERE leads 1 • BACK leads 0 • ATXI leads 0 • XTLB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EBAY leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RERE is the larger business by revenue, generating $18.5B annually — 815762.1x BACK's $22,723. EBAY is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to BACK's -426.9%. On growth, RERE holds the edge at +32.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $18.5B | $22,723 | $11.6B | $1M | $451,000 |
| EBITDAEarnings before interest/tax | $501M | -$9M | $2.6B | -$4M | -$1M |
| Net IncomeAfter-tax profit | $210M | -$10M | $2.0B | -$4M | -$1M |
| Free Cash FlowCash after capex | $0 | -$5M | $1.7B | -$2M | $0 |
| Gross MarginGross profit ÷ Revenue | +20.5% | -18.4% | +72.0% | +100.0% | +26.4% |
| Operating MarginEBIT ÷ Revenue | +1.3% | -398.1% | +19.6% | -2.8% | -4.8% |
| Net MarginNet income ÷ Revenue | +1.1% | -426.9% | +17.6% | -2.7% | -2.3% |
| FCF MarginFCF ÷ Revenue | +3.6% | -215.1% | +14.5% | -124.1% | -3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +32.2% | -62.3% | +19.5% | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.4% | +26.3% | +5.7% | +89.1% | +20.0% |
Valuation Metrics
RERE leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, RERE's 16.1x EV/EBITDA is more attractive than EBAY's 21.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.1B | $77,541 | $48.6B | $2M | $293,767 |
| Enterprise ValueMkt cap + debt − cash | $858M | -$426,648 | $54.1B | -$842,479 | $60,767 |
| Trailing P/EPrice ÷ TTM EPS | -907.40x | -0.00x | 24.52x | -0.61x | -0.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 1.46x | — | 17.40x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 16.11x | — | 21.03x | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.46x | 1.08x | 4.38x | — | 0.65x |
| Price / BookPrice ÷ Book value/share | 2.02x | — | 10.61x | 3.84x | 0.05x |
| Price / FCFMarket cap ÷ FCF | 12.79x | — | 29.28x | — | — |
Profitability & Efficiency
EBAY leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
EBAY delivers a 44.1% return on equity — every $100 of shareholder capital generates $44 in annual profit, vs $-161 for ATXI. XTLB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to EBAY's 1.60x. On the Piotroski fundamental quality scale (0–9), RERE scores 7/9 vs BACK's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.5% | — | +44.1% | -160.6% | -25.5% |
| ROA (TTM)Return on assets | +4.0% | -31.3% | +11.5% | -105.8% | -17.7% |
| ROICReturn on invested capital | +1.0% | — | +16.8% | — | -54.1% |
| ROCEReturn on capital employed | +0.8% | — | +17.4% | -9.0% | -50.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 1 | 6 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.10x | — | 1.60x | — | 0.03x |
| Net DebtTotal debt minus cash | -$1.6B | -$504,189 | $5.5B | -$3M | -$233,000 |
| Cash & Equiv.Liquid assets | $2.0B | $504,189 | $1.9B | $3M | $371,000 |
| Total DebtShort + long-term debt | $355M | $0 | $7.4B | $0 | $138,000 |
| Interest CoverageEBIT ÷ Interest expense | 23.67x | -28.20x | 10.52x | — | -13.31x |
Total Returns (Dividends Reinvested)
EBAY leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EBAY five years ago would be worth $18,633 today (with dividends reinvested), compared to $1 for ATXI. Over the past 12 months, ATXI leads with a +150.1% total return vs XTLB's -50.9%. The 3-year compound annual growth rate (CAGR) favors EBAY at 33.4% vs ATXI's -80.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.8% | -69.7% | +22.6% | -19.8% | +11.3% |
| 1-Year ReturnPast 12 months | +97.4% | +19.4% | +54.2% | +150.1% | -50.9% |
| 3-Year ReturnCumulative with dividends | +113.9% | -99.2% | +137.4% | -99.3% | -45.7% |
| 5-Year ReturnCumulative with dividends | -73.2% | -99.9% | +86.3% | -100.0% | -80.4% |
| 10-Year ReturnCumulative with dividends | -73.2% | -100.0% | +369.5% | -100.0% | -87.3% |
| CAGR (3Y)Annualised 3-year return | +28.8% | -80.2% | +33.4% | -80.7% | -18.4% |
Risk & Volatility
Evenly matched — EBAY and ATXI each lead in 1 of 2 comparable metrics.
Risk & Volatility
ATXI is the less volatile stock with a -0.11 beta — it tends to amplify market swings less than XTLB's 1.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EBAY currently trades 95.5% from its 52-week high vs BACK's 18.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.36x | 0.05x | 0.73x | -0.11x | 1.71x |
| 52-Week HighHighest price in past year | $6.47 | $0.21 | $111.38 | $0.97 | $10.28 |
| 52-Week LowLowest price in past year | $2.34 | $0.03 | $67.87 | $0.15 | $1.05 |
| % of 52W HighCurrent price vs 52-week peak | +69.9% | +18.2% | +95.5% | +56.7% | +26.0% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 40.2 | 63.1 | 54.6 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 3K | 5.4M | 3K | 2.4M |
Analyst Outlook
Evenly matched — BACK and EBAY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RERE as "Buy", EBAY as "Hold". For income investors, BACK offers the higher dividend yield at 100.00% vs EBAY's 1.08%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Hold | — | — |
| Price TargetConsensus 12-month target | — | — | $109.67 | — | — |
| # AnalystsCovering analysts | 2 | — | 68 | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +100.0% | +1.1% | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 7 | — | — |
| Dividend / ShareAnnual DPS | — | $0.80 | $1.15 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.5% | 0.0% | +5.1% | 0.0% | 0.0% |
EBAY leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RERE leads in 1 (Valuation Metrics). 2 tied.
RERE vs BACK vs EBAY vs ATXI vs XTLB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RERE or BACK or EBAY or ATXI or XTLB a better buy right now?
For growth investors, ATRenew Inc.
(RERE) is the stronger pick with 25. 9% revenue growth year-over-year, versus -98. 6% for IMAC Holdings, Inc. (BACK). eBay Inc. (EBAY) offers the better valuation at 24. 5x trailing P/E (17. 4x forward), making it the more compelling value choice. Analysts rate ATRenew Inc. (RERE) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RERE or BACK or EBAY or ATXI or XTLB?
On forward P/E, ATRenew Inc.
is actually cheaper at 1. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — RERE or BACK or EBAY or ATXI or XTLB?
Over the past 5 years, eBay Inc.
(EBAY) delivered a total return of +86. 3%, compared to -100. 0% for Avenue Therapeutics, Inc. (ATXI). Over 10 years, the gap is even starker: EBAY returned +369. 5% versus ATXI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RERE or BACK or EBAY or ATXI or XTLB?
By beta (market sensitivity over 5 years), Avenue Therapeutics, Inc.
(ATXI) is the lower-risk stock at -0. 11β versus XTL Biopharmaceuticals Ltd. 's 1. 71β — meaning XTLB is approximately -1652% more volatile than ATXI relative to the S&P 500. On balance sheet safety, XTL Biopharmaceuticals Ltd. (XTLB) carries a lower debt/equity ratio of 3% versus 160% for eBay Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RERE or BACK or EBAY or ATXI or XTLB?
By revenue growth (latest reported year), ATRenew Inc.
(RERE) is pulling ahead at 25. 9% versus -98. 6% for IMAC Holdings, Inc. (BACK). On earnings-per-share growth, the picture is similar: Avenue Therapeutics, Inc. grew EPS 98. 8% year-over-year, compared to -5. 4% for IMAC Holdings, Inc.. Over a 3-year CAGR, RERE leads at 28. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RERE or BACK or EBAY or ATXI or XTLB?
eBay Inc.
(EBAY) is the more profitable company, earning 18. 3% net margin versus -125. 5% for IMAC Holdings, Inc. — meaning it keeps 18. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EBAY leads at 20. 5% versus -78. 0% for BACK. At the gross margin level — before operating expenses — ATXI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RERE or BACK or EBAY or ATXI or XTLB more undervalued right now?
On forward earnings alone, ATRenew Inc.
(RERE) trades at 1. 5x forward P/E versus 17. 4x for eBay Inc. — 15. 9x cheaper on a one-year earnings basis.
08Which pays a better dividend — RERE or BACK or EBAY or ATXI or XTLB?
In this comparison, BACK (100.
0% yield), EBAY (1. 1% yield) pay a dividend. RERE, ATXI, XTLB do not pay a meaningful dividend and should not be held primarily for income.
09Is RERE or BACK or EBAY or ATXI or XTLB better for a retirement portfolio?
For long-horizon retirement investors, IMAC Holdings, Inc.
(BACK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05), 100. 0% yield). XTL Biopharmaceuticals Ltd. (XTLB) carries a higher beta of 1. 71 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BACK: -100. 0%, XTLB: -87. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RERE and BACK and EBAY and ATXI and XTLB?
These companies operate in different sectors (RERE (Consumer Cyclical) and BACK (Healthcare) and EBAY (Consumer Cyclical) and ATXI (Healthcare) and XTLB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RERE is a small-cap high-growth stock; BACK is a small-cap income-oriented stock; EBAY is a mid-cap quality compounder stock; ATXI is a small-cap quality compounder stock; XTLB is a small-cap quality compounder stock. BACK, EBAY pay a dividend while RERE, ATXI, XTLB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.